#CTMX
BUY_ON_CONFIRMATION $CTMX (CTMX.O) [StrategicCollaboration] New Collaboration; Announced @ 21:15:01Z
November 17, 2026 at 9:15 PM
#CTMX CytomX Therapeutics Announces Milestone Achievement in Strategic Collaboration with Regeneron in the Field of Conditionally…

https://www.stocktitan.net/news/CTMX/cytom-x-therapeutics-announces-milestone-achievement-in-strategic-u4j1pg9k883u.html?utm_source=stocktitan-bluesky&utm_medium=social
CytomX Therapeutics Announces Milestone Achievement in Strategic Collaboration with Regeneron in the Field of Conditionally Activated Bispecifics
CytomX Therapeutics (Nasdaq: CTMX) achieved a preclinical milestone in its collaboration with Regeneron, triggering a $5 million payment to CytomX. The milestone concerns one of the collaboration’s lead programs and is the first achieved under the partnership, which began in 2022 and expanded in June 2026.The collaboration combines CytomX’s PROBODY masking technology with Regeneron’s bispecific antibody platform to develop antibodies designed to activate in the tumor environment rather than throughout the body. Regeneron funds all preclinical and clinical development and commercialization activities. Under the expanded collaboration, CytomX is eligible for up to approximately $4 billion in total potential target nomination and milestone payments, plus tiered royalties on global net sales of any potential covered products.
www.stocktitan.net
November 17, 2026 at 9:15 PM
CytomX Therapeutics ($CTMX) – New 4.1% holder

• Holder: State Street
• Stake: 0 → 4.1% (about $18M)
• About 13G: a passive investor, not seeking to influence the company
• Filed: Nov 10 · Schedule 13G

📊 More at www.elixstocks.com

Educational only. Not investment advice.

#Investing #Stocks
State Street Corp: 4.1% of CytomX Therapeutics ($CTMX)
Schedule 13G filed Nov 10. Who filed, the stake, and how it changed.
elixstocks.com
November 11, 2026 at 9:37 PM
Eli Lilly (#$LLY) signed a deal worth up to $5.9B with private Stipple Bio for tumor-selective binders, before any human data. Small caps testing similar ideas: #$CTMX, #$PYXS, #$STRO, #$XLO.

prismmarketview.com/lilly-puts-a...
Lilly Puts a Price on Tumor Precision as Small Caps Race to Spare Healthy Tissue
A deal worth up to $5.9 billion for private Stipple Bio highlights the race to hit cancer cells while sparing healthy tissue, a problem CytomX, Pyxis Oncology,
prismmarketview.com
November 17, 2026 at 8:25 PM
$TTEC-1 $LIFE-1 $GABC-1 $IPX-1 $AFRM-1 $VET-1 $UPRO-1 $GOOG-1 $HAYW-1 $APO-1 $MCHP-1 $MSFU-1 $OBDC-1 $XLE-1 $RIVN-1 $FITB-1 $CROX-1 $VIAV-1 $DRAM-1 $MAR-1 $SSNC-1 $CNH-1 $XLI-1 $LOPE-1 $ENGS-1 $BAC-1 $CTMX-1 $VIST-1 $AAPL-1 $GFL-1 $UVXY-1 $PHVS-1 $UDOW-1 $DFTX-1 $ADPT-1
November 10, 2026 at 9:21 PM
www.stocktitan.net
November 2, 2026 at 1:00 PM
CytomX Therapeutics ($CTMX) – 13G holder trims

• Holder: Bank of America Corp /DE/
• Stake: 7% → 5.4% (about $28M)
• Shares: 15,134,689 → 11,867,012
• Filed: Oct 28 · Schedule 13G/A

📊 More at www.elixstocks.com

Educational only. Not investment advice.

#Investing #Stocks
Bank of America Corp /de/: 5.4% of CytomX Therapeutics ($CTMX)
Schedule 13G/A filed Oct 28. Who filed, the stake, and how it changed.
elixstocks.com
October 29, 2026 at 1:57 PM
www.stocktitan.net
October 29, 2026 at 12:00 PM
Tyson vs Douglas - the Killers
www.youtube.com/watch?v=cTmX...
Tyson vs Douglas
YouTube video by The Killers - Topic
www.youtube.com
October 17, 2026 at 8:12 PM
🚨 $CTMX
McCarthy Sean A. (CEO) sold 101,793 shares at an average price of $4.5377 per common share. (Date: 2025-11-06)
SEC Filing: CTMX
Click to view the official SEC document.
www.sec.gov
October 16, 2026 at 11:40 PM
Or CTMX 854 ...
September 6, 2026 at 5:49 PM
@autowa.app I think it's CTMX 864, but not certain.
September 6, 2026 at 5:48 PM
BUY $CTMX (CTMX.O) [FDA] @ 12:00:04Z
August 27, 2026 at 12:00 PM
$MRNA raises $2B via convertible notes maturing 2032 to support vaccine and oncology growth. Other movers: $GLUE $GENB $ARTL $DTIL $CTMX $LTRN $NCEL $NXL $TCRT

www.biopharmcatalyst.com/news/2026/ca...
Pre-Market Updates 08/27/26
export-download.canva.com
August 27, 2026 at 12:40 PM
#CTMX CytomX Therapeutics Announces FDA Fast Track Designation for Varsetatug masetecan (“Varseta-M”) for Relapsed/Refractory Metastatic Colorectal Cancer (R/R mCRC)

https://www.stocktitan.net/news/CTMX/cytom-x-therapeutics-announces-fda-fast-track-designation-for-855qglgg57qi.html
CytomX Therapeutics Announces FDA Fast Track Designation for Varsetatug masetecan (“Varseta-M”) for Relapsed/Refractory Metastatic Colorectal Cancer (R/R mCRC)
CytomX Therapeutics (Nasdaq: CTMX) announced that the U.S. FDA has granted Fast Track Designation (FTD) to varsetatug masetecan (Varseta-M) for the treatment of patients with relapsed/refractory metastatic colorectal cancer (R/R mCRC). The designation follows previously reported encouraging Phase 1 data in this setting.Varseta-M (CX-2051) is a potential first-in-class, masked, conditionally activated antibody-drug conjugate directed at EpCAM and armed with a topoisomerase-1 inhibitor payload. CytomX plans to initiate a potential Varseta-M monotherapy registrational study in R/R mCRC in the first half of 2027. The company’s broader pipeline includes CX-801, a masked interferon alpha-2b PROBODY cytokine initially in development for metastatic melanoma, and it maintains collaborations with Amgen, Regeneron and Moderna.
www.stocktitan.net
August 27, 2026 at 12:00 PM
The FDA has granted fast track designation to varsetatug masetecan for R/R mCRC following encouraging data from the phase 1 CTMX-2051-101 trial. 👀 #oncology #CRC
Read more here: www.onclive.com/view/fda-gra...
FDA Grants Fast Track Designation to Varsetatug Masetecan for Relapsed/Refractory Metastatic Colorectal Cancer | OncLive
The FDA has granted fast track designation to varsetatug masetecan for relapsed/refractory metastatic colorectal cancer.
www.onclive.com
August 27, 2026 at 2:50 PM
FDA grants Fast Track to #$CTMX Varseta-M (CX-2051) for relapsed metastatic colorectal cancer as a 2027 pivotal trial and new combinations approach. notreload.xyz/xy/fda-fast-...
FDA Fast Track for CytomX Varseta-M in CRC
FDA grants Fast Track to CytomX’s Varseta-M for relapsed metastatic colorectal cancer as a 2027 pivotal trial and new combinations approach.
notreload.xyz
August 27, 2026 at 12:57 PM
June 25, 2025 at 1:37 AM
Ralf Kalich zeigt sich erfreut, dass die Reaktivierung der #Höllentalbahn zwischen #Thüringen und #Bayern endlich eine neue Perspektive erhält. „Die Strecke ist von großer Bedeutung für den Transport von Industriegütern aber auch für den #Tourismus.“

📺 www.youtube.com/watch?v=CTMX...
November 22, 2023 at 1:00 PM
December 14, 2023 at 7:56 PM
Starfleet's Shield
YouTube video by Certifiably Ingame
www.youtube.com
January 22, 2025 at 2:22 PM
Illustration utile pour vos prochaines présentations sur une faille de sécurité : un vérin hydraulique d'une machine d'usinage d'aluminium qui pète www.youtube.com/watch?v=Ctmx...
A portal to hell at an aluminum plant that swallowed up the entire shop in a matter of seconds.
www.youtube.com
January 10, 2024 at 7:07 AM